Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- MCOV-B.ST
- Price
- 205.50
- Stock movement up
- +4.50 (2.24%)
- Company name
- Medicover AB (publ)
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Care Facilities
- Market cap
- 15.11B
- Ent value
- 16.57B
- Price/Sales
- 7.56
- Price/Book
- 28.64
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 14.69%
- Trailing P/E
- 766.79
- Forward P/E
- 446.74
- PEG
- -
- EPS growth
- -8.61%
- 1 year return
- 46.37%
- 3 year return
- 2.97%
- 5 year return
- 17.11%
- 10 year return
- -
Last updated: 2025-04-15
DIVIDENDS
MCOV-B.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 766.79 |
| Price to OCF | 62.76 |
| Price to FCF | 123.31 |
| Price to EBITDA | 52.18 |
| EV to EBITDA | 57.23 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.56 |
| Price to Book | 28.64 |
| EV to Sales | 8.29 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 73.51M |
| EPS (TTM) | 0.13 |
| FCF per share (TTM) | 0.82 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.00B |
| Gross profit (TTM) | 413.60M |
| Operating income (TTM) | 66.00M |
| Net income (TTM) | 19.70M |
| EPS (TTM) | 0.13 |
| EPS (1y forward) | 0.46 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 20.70% |
| Operating margin (TTM) | 3.30% |
| Profit margin (TTM) | 0.99% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 65.00M |
| Net receivables | 276.10M |
| Total current assets | 422.00M |
| Goodwill | 515.00M |
| Intangible assets | 125.40M |
| Property, plant and equipment | 942.80M |
| Total assets | 2.06B |
| Accounts payable | 234.80M |
| Short/Current long term debt | 1.14B |
| Total current liabilities | 564.00M |
| Total liabilities | 1.53B |
| Shareholder's equity | 527.40M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 240.70M |
| Capital expenditures (TTM) | 118.20M |
| Free cash flow (TTM) | 122.50M |
| Dividends paid (TTM) | 18.00M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 3.74% |
| Return on Assets | 0.96% |
| Return on Invested Capital | 1.58% |
| Cash Return on Invested Capital | 9.82% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 202.00 |
| Daily high | 206.00 |
| Daily low | 201.00 |
| Daily Volume | 30K |
| All-time high | 370.00 |
| 1y analyst estimate | 223.47 |
| Beta | 1.46 |
| EPS (TTM) | 0.13 |
| Dividend per share | - |
| Ex-div date | 29 Apr 2024 |
| Next earnings date | 24 Apr 2025 |
Downside potential
Loading...
Downside potential data
| MCOV-B.ST | S&P500 | |
| Current price drop from All-time high | -44.46% | -12.04% |
| Highest price drop | -69.59% | -56.47% |
| Date of highest drop | 27 Sep 2022 | 9 Mar 2009 |
| Avg drop from high | -27.01% | -11.07% |
| Avg time to new high | 21 days | 12 days |
| Max time to new high | 828 days | 1805 days |
COMPANY DETAILS
Marketcap
15.11B
Marketcap category
Large-cap
Description
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Employees
45000
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As the European market navigates a complex landscape of trade tensions and economic uncertainties, the pan-European STOXX Europe 600 Index has managed to break a two-week losing streak, buoyed by hope...
March 27, 2025
As February 2025 unfolds, global markets are grappling with geopolitical tensions and consumer spending concerns, leading to fluctuating indices and cautious investor sentiment. Amid these uncertainti...
February 26, 2025
In a week marked by choppy markets and inflation concerns, global indices have experienced notable fluctuations, with U.S. equities seeing declines amid political uncertainties and economic data relea...
January 15, 2025
In a week marked by record highs in major U.S. stock indexes, growth stocks have notably outperformed their value counterparts, driven by strong performances in sectors like consumer discretionary and...
December 12, 2024
The board of directors of Medicover AB (Publ) has today decided to evaluate the opportunity to list the Indian hospital subsidiary in India over the coming 12-24 months to further support its growth a...
December 10, 2024
In a week marked by busy earnings reports and economic data, global markets saw major indexes mostly lower, with growth stocks lagging behind value shares. Amid such volatility, identifying growth com...
November 7, 2024
Medicover AB reports robust financial performance with significant revenue growth, while navigating challenges in Germany and India.
October 31, 2024
Medicover AB (FRA:5M0B) reports strong revenue growth and operational improvements, while navigating challenges in new markets and inflationary pressures.
October 9, 2024
As global markets navigate through heightened geopolitical tensions and economic uncertainties, the Swedish market remains a focal point for investors seeking growth opportunities. In this environment...
October 9, 2024
In September 2024, the Swedish market has been navigating through global economic uncertainties, with European indices experiencing notable declines amid fears of a slowdown in global growth. Despite ...
September 10, 2024
Next page